Logo

Shukra Pharmaceuticals Limited Share Price

BSE: 524632
|
Pharmaceuticals
₹ 32.39
+₹2.94 (9.98%)
1D
Last updated 03 Jul, 2026, 15:29 IST

Shukra Pharmaceuticals Limited Share Price Today

As of 5 Jul 2026, Shukra Pharmaceuticals Limited share price is ₹32.39. The stock opened at ₹29.75, compared to its previous close of ₹29.45. During today's trading session, Shukra Pharmaceuticals Limited share price moved in the range of ₹29.01 to ₹32.39, with an average price of ₹30.70 for the day. Looking at its last 52-week, the stock has touched a low of ₹16.59 and a high of ₹65.26.

₹29.01
9.98% up today
₹32.39
1D LOW
1D HIGH

Shukra Pharmaceuticals Limited Returns Calculator

Open
₹29.75
High
₹32.39
Low
₹29.01
Prev. close
₹29.45
Circuit
L
H
₹28.52
₹34.84
52-week
L
H
₹16.59
₹65.26

Shukra Pharmaceuticals Limited Shareholder Returns

Shukra Pharmaceuticals Limited Share Price History

Mkt Cap Cr
1,289.55
P/E
58.90
P/B
14.35
ROE
24.55%
D/E
0.06
ROCE
31.50%
Div. Yield
0.03%
EPS(TTM)
0.50
Turnover
0.60
EV/EBITDA
37.94
Net Margin
0.00%
Op. Margin
0.00%
ROA
18.78%
Quick Ratio
0.00
Curr. Ratio
3.94
Based on fundamentals, this stock's
Step 2 of 5
Performance
Poor
Shukra Pharma. has underperformed the market
Step 1 of 5
Valuation
Overvalued
Shukra Pharma. appears overvalued compared to its peers
Step 3 of 5
Earnings
Neutral
Shukra Pharma. earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,49,048.0039.025.3713.74%0.6117.33%93.240.85%0.5610.90
Divis Laboratories1,77,179.0069.0010.5715.32%0.0019.56%629.490.45%0.5898.19
Torrent Pharmaceuticals1,57,804.0066.0317.0326.76%1.0518.30%16.900.90%0.4964.75
Cipla1,17,642.0025.472.8711.79%0.0015.66%2.891.06%0.4943.52
Dr. Reddy's Laboratories1,12,368.0027.032.9711.07%0.1812.54%375.780.59%0.6338.68
Zydus Lifesciences1,10,651.0021.604.0818.59%0.3117.35%235.250.09%0.3935.38
Lupin1,09,676.0020.484.8923.76%0.0424.88%659.050.75%0.61129.18
Mankind Pharma1,02,729.0053.006.3011.74%0.3413.13%397.020.04%0.5449.37
Aurobindo Pharma90,608.0025.872.399.25%0.1911.76%391.140.26%0.4841.58
Laurus Labs82,398.9060.2610.1018.21%0.4516.70%10.190.20%0.9713.72

Shukra Pharmaceuticals Limited Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2026
Revenue36.861.31
Operating profit13.3428.79
Net profit9.5822.06

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹32.59₹74.57₹58.83₹20.49
Other Income₹4.21₹2.82₹1.20₹0.08
Total Revenue₹36.79₹77.39₹60.03₹20.57
Total Expenses₹23.46₹57.50₹55.59₹19.55
Profit Before Tax₹13.34₹19.88₹4.44₹1.02
Tax₹3.76₹1.35₹0.04₹0.27
Profit After Tax₹9.58₹18.54₹4.41₹0.75
EPS - Basic₹0.22₹16.93₹26.21₹4.79
EPS - Diluted₹0.22₹16.93₹26.21₹4.79

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹13.34₹19.88₹4.44₹1.02
Income before WC changes₹15.46₹21.43₹6.04₹2.93
Change in Assets-₹7.06₹2.85-₹33.27₹0.44
Change in Liabilities₹3.28-₹28.85₹30.64₹5.06
Change in WC-₹3.78-₹26.01-₹2.62₹5.50
Cash flow from Operations₹7.92-₹5.20₹3.17₹7.99
Cash flow from Investing-₹1.26-₹1.20-₹4.43-₹1.53
Cash flow from Financing-₹4.52₹12.41₹4.94-₹6.68
Total Cash Flow₹2.14₹6.01₹3.68-₹0.21
Cash (Start of the year)₹9.98₹3.97₹0.29₹0.50
Cash (End of the year)₹12.12₹9.98₹3.97₹0.29

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹21.34₹21.60₹21.89₹19.24
Current Assets₹65.43₹56.23₹53.07₹15.87
Total Assets₹86.77₹77.84₹74.97₹35.11
Current Liabilities₹17.28₹14.15₹42.51₹12.38
Net Current Asset₹48.14₹42.08₹10.57₹3.50
Non-Current Liabilities₹6.65₹6.04₹7.16₹6.39
Equity Capital₹62.84₹57.64₹25.30₹16.35
Total Equity & Liabilities₹86.77₹77.84₹74.97₹35.11
* All values are in INR Crore
Qty
Bid
35651
32.39
1
32.35
3000
32
100
31.8
5000
31.7
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 43752
Ask Total: 0
Buy orders: 100%
Sell orders: 0%
Bearish
4
Neutral
3
Bullish
1
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
58.66
Neutral
ATR (14)
1.47
Neutral
STOCH(9,6)
83.33
Bearish
STOCH RSI (14)
100
Bearish
ADX(9)
20.03
Bearish
UO(9)
56.24
Neutral
ROC(12)
1.7
Bullish
WillR(14)
-16.67
Bearish
Period
Simple value
Exponential vaue
5D
29.46
30.01
10D
29.53
29.8
20D
30.17
29.9
50D
30.38
31.12
100D
34.27
33.86

About Shukra Pharmaceuticals Limited

Shukra Pharmaceuticals Limited logo
ISIN
INE551C01044
Sector Market Cap
₹ 1,289.55 Cr

Shukra Pharmaceuticals Limited is an India-based pharmaceutical company engaged in developing, manufacturing and marketing a range of pharmaceutical products globally and domestically. The Company’s product portfolio consists of tablet and capsules (general) solid oral dosage form and small volume parenteral- liquid injection vial and ampules. The Company’s products include Losartan Potassium Tablets USP 50 mg, Glimepiride Tablets USP 2 mg, Pantoprazole Tablets USP 40 mg, Methocarbamol Tablets USP 500 mg, Omeprazole Capsule IP 20 mg, Amlodipine besylate Tablets USP 5 mg, Ranitidine Tablets USP 150 mg, Ranitidine Tablets USP 300 mg, Ciprofloxacin Tablets USP 250 mg, Ciprofloxacin Tablets USP 500 mg, Atorvastatin Tablets USP 10mg, Sildenafil citrate Tablets BP 100 mg, Diclofenac Sodium Tablets BP 50 mg, Mebendazole Tablets USP 100 mg, Paracetamol Tablets BP 500 mg, Artemether 80 mg and Lumefantrine 480 mg Tablets, Clotrimazole Vaginal Tablets 100 mg and others.

Shukra Pharmaceuticals Limited Financial Highlights

  • Revenue: Shukra Pharmaceuticals Limited reported revenue of ₹61.31 crore in FY26 vs ₹36.80 crore in FY25. It showed an increase of 66.60% on a yearly basis.
  • Operating Profit: Shukra Pharmaceuticals Limited reported an operating profit of ₹28.79 crore in FY26 vs ₹13.34 crore in FY25. It showed an increase of 115.82% on a year-on-year basis.
  • Net Profit: Shukra Pharmaceuticals Limited reported a net profit of ₹22.06 crore in FY26 vs ₹9.58 crore in FY25. It showed an increase of 130.27% on a yearly basis.

Shukra Pharmaceuticals Limited Quarterly Result Highlights

  • Shukra Pharmaceuticals Limited reported revenue of ₹7.27 crore in Mar 2026, compared with ₹39.95 crore in Dec 2025, representing a decrease of 81.80% on a quarter-on-quarter (QoQ) basis.
  • Shukra Pharmaceuticals Limited reported an operating profit of ₹0.38 crore in Mar 2026, compared with ₹26.83 crore in Dec 2025, representing a decrease of 98.58% on a quarter-on-quarter (QoQ) basis.
  • Shukra Pharmaceuticals Limited reported a loss of ₹1.72 crore in Mar 2026, compared with ₹20.36 crore in Dec 2025, reflecting a decrease of 108.45% on a QoQ basis.
Know more
Promoters
50.96%
FII
0.00%
Other DII
0.11%
Retail and other
48.93%
Mutual funds
0.00%
Foreign institutions - FII
Compare against other stocks
Shukra Pharmaceuticals Limited logo
Shukra Pharmaceuticals Limited
Pharmaceuticals
Add Stock
Add Another

FAQs on Shukra Pharmaceuticals Limited Share Price